Lonza opens early-phase development, manufacturing facility
WEBJun 14, 2022 · The company has completed its early-phase development and manufacturing facility in Bend, giving it 11 processing suites focused on first steps into the clinic. Switzerland-based Lonza gained a presence in Bend through its 2016 takeover of Capsugel, which had itself picked up the Oregon site in its acquisition of Bend Research a few years earlier.
Specialized CRO ‘fills the gap’ for rare disease research
WEBFeb 28, 2022 · Orphan Reach tries to fill the gap between the traditional global CRO, mostly focused on managing larger trials in common diseases, and the needs of companies that develop rare disease treatments for only a few patients. We have been operating on a global scale in more than 70 countries pretty much from …
Care Access Research, Lilly join on mobile COVID-19 trials
WEBOct 27, 2020 · Eli Lilly and research site partner Care Access Research are doing just that with the BLAZE-2 Phase III trial of Lilly’s monoclonal antibody (mAb) LY-CoV555, a treatment the pharma firm hopes is effective in treating the COVID-19 virus. Outsourcing-Pharma (OSP) spoke with Ahmad Namvargolian (AN), CEO and co …
UDG acquires MicroMass for $75.8m to meet patient engagement …
WEBSep 20, 2017 · UDG Healthcare acquired MicroMass Communications in a deal worth up to $75.8m. The US-based healthcare communications agency specializes in behavioral change, patient support, and adherence services. Jez Moulding, EVP of Ashfield and COO of UDG Healthcare plc told us the acquisition of MicroMass is strategically important for Ashfield and UDG ...
AI-enabled pharma manufacturing tech pinpoints risk
WEBJul 14, 2020 · The two companies are collaborating on AI-enabled risk detection, intended to increase pharma product quality and process efficiency. Quartic.ai is joining forces with Sparta Systems to develop artificial intelligence (AI) based solutions to detect risks early in the pharmaceutical manufacturing process. The goal is to come up with solutions ...
Clinical Supply Blockchain Working Group led by Pfizer and Biogen ...
WEBAug 14, 2019 · Pfizer, Biogen-led blockchain project demonstrates proof-of-concept in pursuit of a better supply chain. The multi-stakeholder group is developing a blockchain-powered platform to increase transparency and collaboration in the clinical trial supply chain – and has successfully completed a proof-of-concept project, now looking to next steps.
WuXi STA opens manufacturing line with 10m unit capacity
WEBDec 5, 2022 · The new line possesses a fully automatic vial loading/unloading system, and has the annual capacity to produce 10 million units. The line has a filling speed of 200 vials per minute. WuXi STA’s new filling line adds significantly to the capacity provided by the first line, which was added in January 2022. The first line has a capacity of 2 ...
Veeva launches Vault CTMS with Bristol Myers Squibb
WEBMay 17, 2022 · Veeva has introduced that its Vault clinical trial management system (CTMS) was put in place at Bristol Myers Squibb (BMS). According to the cloud software provider, the implementation of the CTMS helped bring together two heritage systems into one in a relatively short time. To learn more about how Vault installation can help companies like ...
How Clario is improving clinical trials: 'Therapies that hold …
WEBDec 11, 2023 · Dr. Michael O’Neal, chief medical officer at Clario, believes that many drugs ultimately fail due to common operational and data challenges that could, and should, be corrected.
Premier Research: holistic approach benefits development
WEBOct 6, 2020 · Holistic design starts off with designing a target product profile that considers the end goal early in the development planning. Also, part of a successful holistic approach, Sharif suggested, is asking thoughtful, appropriate questions at the outset, making sure to consider outcome-focused impactful issues at every stage of development.
Skip to content